-
What Every MS Patient Should Know About Ocrevus and Its Use
With the approval of Ocrevus (ocrelizumab) for both primary progressive and relapsing multiple sclerosis (MS), interest in the medication is peaking. To help readers of Multiple Sclerosis News Today better understand this new medication and how it works, as well as issues dealing with access, use, and potential side effects, here is a summary of the most relevant information now available about Ocrevus.
Comments and concerns expressed by many readers on our different platforms were taken into consideration in writing this article.
The basics
Ocrevus is a prescription medication, so people considering the treatment should discuss with their physicians whether it may be suitable for them.Genentech — Ocrevus’s developer — is working to make sure that patients receive adequate information about the therapy. The company has set up a website — http://www.ocrevus.com — with detailed information. Patients can also call 1-844-627-3887 (Ocrevus Connects, Monday to Friday, from 9 am to 8 pm ET) with questions concerning this therapy.
Read more about Ocrevus here: “What Every MS Patient Should Know About Ocrevus and Its Use“
Have you tried (or know someone who’s tried) this treatment? Share your experience below.
-
0 Replies
Sorry, there were no replies found.
Log in to reply.